Ainos, Inc. (AIMD)
NASDAQ: AIMD · Real-Time Price · USD
3.530
+0.080 (2.32%)
Sep 11, 2025, 11:02 AM - Market open
Ainos Employees
Ainos had 44 employees as of December 31, 2024. The number of employees decreased by 2 or -4.35% compared to the previous year.
Employees
44
Change (1Y)
-2
Growth (1Y)
-4.35%
Revenue / Employee
$2,520
Profits / Employee
-$357,371
Market Cap
16.80M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44 | -2 | -4.35% |
| Dec 31, 2023 | 46 | 3 | 6.98% |
| Dec 31, 2022 | 43 | 8 | 22.86% |
| Dec 31, 2021 | 35 | 31 | 775.00% |
| Dec 31, 2020 | 4 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AIMD News
- 3 days ago - Ainos to Showcase AI Nose at SEMICON Taiwan 2025 - Accesswire
- 16 days ago - Water Tower Research Fireside Chat with Ainos: AI Nose Sets New Bar in AI Scent Digitization, Eyes 2026 Scale-Up - Accesswire
- 23 days ago - Water Tower Research Initiates Technology Coverage of Ainos, Highlighting Its Leadership and Advancement in AI-Powered Olfactory Innovation - Accesswire
- 4 weeks ago - Ainos Debuts World's First Patented AI Nose Device, Bringing Machine Scent Intelligence to Industry and Healthcare - Accesswire
- 4 weeks ago - Ainos Reports Second Quarter 2025 Financial Results - Accesswire
- 4 weeks ago - Ainos to Participate in Fireside Chat with Water Tower Research on August 20, 2025 - Accesswire
- 5 weeks ago - Ainos Secures $2.1 Million Order With ASE for First Deployment of AI Nose in Semiconductor Manufacturing Setting - Accesswire
- 5 weeks ago - Ainos Receives TFDA Approval to Initiate Clinical Study of VELDONA for Primary Sjögren's Syndrome - Accesswire